Company / SG&A Expense
Cooper Companies (The) SG&A Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$1.6B
FY2025
5-year range
$1.2B / $1.6B
FY2021-FY2025
Trend
+6.1%
vs FY2024
Sector context
#33 of 152
Health Care
What the data says
Cooper Companies (The)'s sg&a expense of $1.6B is higher than 78% of companies in the Health Care sector (FY2025). SG&A Expense has increased for 5 consecutive years, from $993M in FY2020 to $1.6B in FY2025.
Based on SEC 10-K filings.
$1.6B in FY2025 with a 5-year CAGR of +10.4%. Top quartile in the Health Care sector.
Increased from $1.5B to $1.6B over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +6.6%
- 5-Year CAGR
- +10.4%
- 10-Year CAGR
- -
Sector benchmark
Bottom 22% in Health CareTop 78% of 152This company $1.6B Sector average $182.7B
▼
-99.1% below sector average
Key checks
Key Insights
- Cooper Companies (The)'s sg&a expense has grown for 5 consecutive years.
- 5-year CAGR of +10.4%, indicating consistent growth.
- In FY2025, sg&a expense increased 6.1% year-over-year.
- Ranks #33 out of 152 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.6B | +6.1% |
| FY2024 | $1.5B | +2.2% |
| FY2023 | $1.5B | +11.8% |
| FY2022 | $1.3B | +10.8% |
| FY2021 | $1.2B | +22.0% |
| FY2020 | $992.5M | -0.4% |
| FY2019 | $996.2M | +2.4% |
| FY2018 | $973.3M | +21.8% |
| FY2017 | $799.1M | +10.6% |
| FY2016 | $722.8M | +1.4% |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026